Successful engineering controls for 1-, and 2-bromopropane exposures in spray adhesive applications.
Authors
Harney J; Mortimer V; Reh C
Source
American Industrial Hygiene Conference and Exposition, June 1-6, 2002, San Diego, California. Fairfax, VA: American Industrial Hygiene Association, 2002 Jun; :63
Link
NIOSHTIC No.
20022455
Abstract
NIOSH investigators conducted Health Hazard Evaluations at two companies that fabricate foam seat cushions. Historically, different solvent vehicles, such as methylene chloride and acetone have been used to fabricate cushions. 1-bromopropane (usually with residual amounts of 2-bromopropane present as a contaminant of refinement) has been used due to its favorable flammability properties (compared to acetone) and its potentially reduced toxicity hazard compared to methylene chloride. Because little information is available regarding the toxicological effects of this compound in humans, NIOSH has recommended that workplace exposures be lowered as much as possible. Methods: Full-shift exposures to 1-, and 2- bromopropane for spray booth operators were assessed both before and after local exhaust ventilation controls were improved at two plants. At the second plant, short-term (15 minute) exposures were also assessed before and after improvements to engineering controls were made. All air samples were analyzed according to a NIOSH Draft Method for 1-, and 2-bromopropane. In Plant #1, the construction of ventilation booths that enclosed each spray station resulted in a decrease in 1-bromopropane mean full-shift concentrations from over 160 ppm to below 30 ppm. In Plant #2, fully enclosing the already existing ventilated spray booths resulted in a similar decrease from 62 ppm to 22 ppm. Short-term samples with 1-bromopropane peaks as high as 174 ppm at Plant #1 were reduced to below 56 ppm. Exposures to 2-brompropane were decreased similarly. Personal exposures to I-bromopropane can be controlled in spray applications by using rather simple engineering control strategies.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.